MS Speaks

Multiple Sclerosis => TREATMENTS => TECFIDERA (dimethyl fumarate, BG-12, Fumaderm) => Topic started by: agate on September 04, 2017, 09:29:59 pm

Title: Tecfidera shows promise as replacement MS therapy for Tysabri
Post by: agate on September 04, 2017, 09:29:59 pm
An article in Multiple Sclerosis News Today (August 31, 2017) concerns a study indicating that Tecfidera might be a successful "exit strategy" for persons at high risk of adverse events upon discontinuing Tysabri.

https://multiplesclerosisnewstoday.com/2017/08/31/ms-drug-tecfidera-shows-promise-replacement-therapy-tysabri/?utm_source=Multiple+Sclerosis&utm_campaign=f8cb5166a4-RSS_MONDAY_EMAIL_CAMPAIGN&utm_medium=email&utm_term=0_b5fb7a3dae-f8cb5166a4-72136581 (https://multiplesclerosisnewstoday.com/2017/08/31/ms-drug-tecfidera-shows-promise-replacement-therapy-tysabri/?utm_source=Multiple+Sclerosis&utm_campaign=f8cb5166a4-RSS_MONDAY_EMAIL_CAMPAIGN&utm_medium=email&utm_term=0_b5fb7a3dae-f8cb5166a4-72136581)